Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-428,720
Closed -$6.3M 11448
2025
Q3
$6.3M Buy
+428,720
New +$4.37M ﹤0.01% 3071
2025
Q1
Sell
-151,997
Closed -$1.33M 9710
2024
Q4
$1.19M Buy
151,997
+13,269
+10% +$109K ﹤0.01% 5048
2024
Q3
$1.03M Sell
138,728
-259,071
-65% -$2.18M ﹤0.01% 5837
2024
Q2
$3.19M Buy
397,799
+282,377
+245% +$2.52M ﹤0.01% 3722
2024
Q1
$1.34M Buy
115,422
+26,125
+29% +$289K ﹤0.01% 4854
2023
Q4
$997K Sell
89,297
-84,653
-49% -$778K ﹤0.01% 5559
2023
Q3
$2.69M Sell
173,950
-424,187
-71% -$7.12M ﹤0.01% 3549
2023
Q2
$11.3M Buy
598,137
+379,761
+174% +$6.67M ﹤0.01% 1778
2023
Q1
$3.33M Buy
218,376
+117,135
+116% +$1.53M ﹤0.01% 3005
2022
Q4
$1.29M Buy
101,241
+81,441
+411% +$733K ﹤0.01% 4574
2022
Q3
$115K Buy
+19,800
New +$87K ﹤0.01% 8571

Other funds holding ETNB

Jane Street's ETNB Position: Q4 2025 in Review

Jane Street sold out of 89bio (ETNB) in Q4 2025, closing a stake of 428,720 shares — an estimated $6.3M sold.

Jane Street first reported a position in ETNB in Q3 2022 and held it in 11 quarters. The position peaked at $11.3M in Q2 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Jane Street reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Jane Street sold 428,720 89bio shares in Q4 2025, an estimated $6.3M.
  • Jane Street first reported a position in 89bio in Q3 2022 and held it in 11 quarters.
  • Jane Street's 89bio position peaked at $11.3M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.